← Back to Clinical Trials
Recruiting NCT06784674

NCT06784674 Maternal Abdominal Morphology Assessment

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06784674
Status Recruiting
Phase
Sponsor University of Texas at Austin
Condition Pregnancy Related
Study Type OBSERVATIONAL
Enrollment 87 participants
Start Date 2025-05-06
Primary Completion 2030-12

Trial Parameters

Condition Pregnancy Related
Sponsor University of Texas at Austin
Study Type OBSERVATIONAL
Phase N/A
Enrollment 87
Sex FEMALE
Min Age 18 Years
Max Age 54 Years
Start Date 2025-05-06
Completion 2030-12
Interventions
No intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Previous studies have shown that pancreas size tends to be smaller in individuals with diabetes compared to those without diabetes. The investigators have recently found that pancreas size increases during pregnancy. The MAMA study aims to examine changes in the pancreas that occur during pregnancy, in both pregnant mothers and their babies, and find out how they are affected by maternal diabetes. The MAMA study is a prospective cohort study that will follow women and their babies through pregnancy and one year postpartum. Women aged 18-54, who are under 14 weeks pregnant are being recruited to participate in the MAMA study.

Eligibility Criteria

Inclusion Criteria: * Pregnant women, with a singleton gestation * Age 18 - 54 years at screening * Gestational age \< 14 weeks * Willing to commit to 1 year postpartum follow up * Planning to remain in geographical vicinity of Austin for 1 year after delivery Exclusion Criteria: * Presence of any mechanically or magnetically activated implants * Claustrophobia * Other contraindication for MRI * BMI ≥ 38.0 or maximum width less than 48 cm (necessary to fit within the MRI field of view)

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology